IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
20 hedge funds and large institutions have $3.75M invested in Interpace Biosciences, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$314K | |
| 2 | +$30K | |
| 3 | +$28.8K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$24K |
| 5 |
VF
Virtu Financial
New York
|
+$11K |
Top Sellers
| 1 | -$194K | |
| 2 | -$160K | |
| 3 | -$57K | |
| 4 |
Jane Street
New York
|
-$36K |
| 5 |
WP
WealthSource Partners
San Luis Obispo,
California
|
-$11.6K |